ArticleMolecular oncology2024

CDK4/6 inhibitors induce breast cancer senescence with enhanced anti-tumor immunogenic properties compared with DNA-damaging agents.

Dong Hyun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.